Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.4% |
| 2 | Technology | 3.32% |
| 3 | Consumer Discretionary | 2.87% |
| 4 | Financials | 2.84% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BZUN
1001
PUT
Baozun
BZUN
$164M
| $33.8M | 0.01% |
878,400
+455,200
| +108% | +$14.3M |
|
1002
CALL
Novartis
NVS
$290B
| $33.8M | 0.01% |
386,600
+61,200
| +19% | +$5.28M |
|
1003
CALL
State Street SPDR S&P Retail ETF
XRT
$643M
| $33.7M | 0.01% |
786,500
+487,000
| +163% | +$18.5M |
|
1004
Enbridge
ENB
$112B
| $33.7M | 0.01% |
1,108,230
-654,748
| -37% | -$20.1M |
|
1005
iShares MSCI India ETF
INDA
$6.58B
| $33.7M | 0.01% |
1,161,332
+1,093,855
| +1,621% | +$29.3M |
|
|
NEWR
1006
DELISTED
New Relic, Inc.
NEWR
| $33.7M | 0.01% |
488,647
-209,783
| -30% | -$12.5M |
|
1007
Popular Inc
BPOP
$11.2B
| $33.5M | 0.01% |
902,204
+316,673
| +54% | +$11.8M |
|
1008
Aramark
ARMK
$16.1B
| $33.5M | 0.01% |
+2,056,546
| New | +$36.1M |
|
1009
Federated Hermes
FHI
$4.7B
| $33.5M | 0.01% |
1,412,670
+523,082
| +59% | +$11.6M |
|
1010
CALL
Vanguard Real Estate ETF
VNQ
$39.1B
| $33.5M | 0.01% |
426,100
-17,600
| -4% | -$1.33M |
|
1011
CALL
Nucor
NUE
$61.7B
| $33.4M | 0.01% |
807,300
+390,500
| +94% | +$15.8M |
|
|
1012
PUT
State Street SPDR S&P Retail ETF
XRT
$643M
| $33.2M | 0.01% |
775,000
-231,100
| -23% | -$8.77M |
|
1013
Penumbra
PEN
$12.9B
| $33.2M | 0.01% |
185,712
+157,818
| +566% | +$27.4M |
|
|
IRBT
1014
CALL
DELISTED
iRobot
IRBT
| $33.1M | 0.01% |
395,100
-53,300
| -12% | -$3.51M |
|
1015
Zymeworks
ZYME
$1.77B
| $33.1M | 0.01% |
918,450
+492,964
| +116% | +$18.2M |
|
|
BPMC
1016
DELISTED
Blueprint Medicines
BPMC
| $33.1M | 0.01% |
424,610
-21,457
| -5% | -$1.45M |
|
1017
Corteva
CTVA
$50.4B
| $33M | 0.01% |
1,233,439
+233,771
| +23% | +$6.08M |
|
1018
Dana Inc
DAN
$3.2B
| $33M | 0.01% |
2,708,269
+973,491
| +56% | +$10.6M |
|
1019
Visa
V
$682B
| $32.9M | 0.01% |
170,423
+39,447
| +30% | +$7.21M |
|
|
TECX
1020
Tectonic Therapeutic
TECX
$720M
| $32.8M | 0.01% |
156,807
-6,083
| -4% | -$1.25M |
|
|
WWE
1021
DELISTED
World Wrestling Entertainment
WWE
| $32.8M | 0.01% |
753,989
+529,746
| +236% | +$22.7M |
|
|
K
1022
PUT
DELISTED
Kellanova
K
| $32.8M | 0.01% |
528,134
+155,490
| +42% | +$9.41M |
|
|
1023
PUT
Vanguard Real Estate ETF
VNQ
$39.1B
| $32.7M | 0.01% |
416,900
+152,000
| +57% | +$11.5M |
|
1024
US Foods
USFD
$24B
| $32.7M | 0.01% |
1,658,099
+1,212,428
| +272% | +$23.2M |
|
1025
AXIS Capital
AXS
$7.26B
| $32.7M | 0.01% |
805,379
-61,552
| -7% | -$2.37M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.